Research

The evidence behind AURA.

Conceivable's work is built on peer-reviewed science, registered clinical studies, and partnerships with leading academic centres.

Highlights

  • Automation of Day Zero in the IVF Lab

    Automated oocyte retrieval, denudation, sperm preparation and ICSI: a proof-of-concept and the first live births


    Human Reproduction, 2026


    Prototype systems carried out the Day 0 IVF steps in sequence and the work produced five healthy live births. The first from an automated Day 0 workflow.

    Read the paper →

  • Remote ICSI

    A digitally controlled, remotely operated ICSI system: case report of the first live birth


    RBMO Journal


    The first live birth from a remotely-operated ICSI; micro-injection performed under digital control by a human operator, with no on-site presence and no direct physical handling. Expert micro-injection, decoupled from location.

    Read the paper →

  • Cost-to-Baby: Economic Analysis

    Cost-to-baby as a share of household income predicts population-level access to ART


    Presented at ESHRE 2026


    In a study spanning over 95% of IVF cycles worldwide, across 25 countries and regions, small reductions in the net cost of a baby produce disproportionately large gains in access. Cost, not awareness or demand, is the binding constraint.

View all publications →

Clinical Study Protocols

  • Automation of the in Vitro Fertilization Laboratory

    ClinicalTrials.gov NCT06581068


    A prospective study of the full AURA system, with one in four eggs randomised to standard manual care for comparison, under laboratory-manager oversight and a non-inferiority design.

    View on ClinicalTrials.gov →

  • Automation of Gamete Preparation, ICSI, Embryo Culture, and Vitrification

    ClinicalTrials.gov NCT06074835


    The study behind our first results: individual automation and digital control of each laboratory step. It produced the Day Zero and Remote ICSI live births above.

    View on ClinicalTrials.gov →

Research Partners

Embryotools works with Conceivable to ensure rigorous testing and validation, conducting experiments ranging from standard MEAs to preclinical protocol adaptations and safety evaluations.

A research collaboration with the Robotics & Machine Vision Lab, jointly developing the next generation of models for embryology: world models, vision-language-action (VLA) models, and an embryology foundation model.

The IVIRMA and Conceivable will clinically validate AURA in the US with clinical operations in 2027, through a phased program of site acceptance testing and an IRB-governed commercial pilot.